Anti-Hepatitis B Virus Surface Antigen antibody [S14] (ab8636)


  • Product nameAnti-Hepatitis B Virus Surface Antigen antibody [S14]
    See all Hepatitis B Virus Surface Antigen primary antibodies
  • Description
    Mouse monoclonal [S14] to Hepatitis B Virus Surface Antigen
  • SpecificityThis antibody reacts with HBV Small Surface Antigen
  • Tested applicationsSuitable for: ELISA, IHC-FoFr, IHC-Fr, IP, ICC/IFmore details
  • Immunogen

    Purified serum HBV surface antigen

  • Epitopeunknown



Our Abpromise guarantee covers the use of ab8636 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA Use at an assay dependent concentration.
IHC-FoFr 1/100.
IHC-Fr 1/100.
IP Use at an assay dependent concentration.
ICC/IF 1/100.


  • RelevanceHepatitis B Virus (HBV) infection induces a disease state which manifests itself in a variety of ways, characterized by the extent of liver damage, inflammation and viral persistence. HBV infection is also associated with a 100 fold increased risk of hepatocellular carcinoma and currently infects over 250 million people worldwide. HBV has a partially double stranded 3.2 kilobase DNA genome which contains four open reading frames. One of these encodes a 154 amino acid protein called the HBx protein. HBx has been shown to be a transcriptional transactivator of both viral and cellular promoters. Lacking a DNA binding domain and nuclear localization signal, HBx is believed to exert transcriptional activity through protein protein interaction.
  • Cellular localizationVirion membrane
  • Alternative names
    • Large envelope protein antibody
    • Large surface protein antibody
    • LHB antibody
    • Major surface antigen antibody

References for Anti-Hepatitis B Virus Surface Antigen antibody [S14] (ab8636)

This product has been referenced in:
  • Obeng-Adjei N  et al. DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques. Cancer Gene Ther 20:652-62 (2013). Read more (PubMed: 24310062) »

See 1 Publication for this product

Product Wall

Here are a few specific sELISA protocol details I was able to find:

ab2039, the capture antibody, was coated on the plate at 5 μg/ml in 0.1 M carbonate buffer, and the HRP-conjugated detection antibody, ab2042, was used at 0.5-5 ug/mL. Read More

If you don't mind providing a more complete protocol for the ELISA assay you ran, I can help you to troubleshoot further.

We have already tested ab2039 to work successfully with ab2042 in sandwich ELISA.

We have not yet de...

Read More

Thank you for your inquiry. I can confirm that this antibody will recognize all three forms of Hepatitis B Virus Surface Antigen: L form (preS1/preS2/S) or M form (preS2/S) or S form (S). So you can expect up to three bands on the SDS gel depen...

Read More

Thank you for contacting Abcam. I have heard back from the lab about ab8636 and they have told me that the antibody was provided as a bioreactor harvest and so no further purification is needed for any of the assays. They also informed me that protein ...

Read More

Virtually all anti-HBsAg mabs (including this one) are conformation-specific, i.e., they recognize only native antigen. That's why they do not work usually neither in WB nor in denaturing ELISA. ab18797 will work in both of those assays, but only the...

Read More